Who is sponsoring NCT03089931?

NCT03089931 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03089931?

Interventions in NCT03089931: Cervical spinal surgery.

What condition does NCT03089931 study?

NCT03089931 studies Cervical Myelopathy Spondylosis, Low Back Pain.

Is NCT03089931 still recruiting?

NCT03089931 is currently completed. Last updated 22 October 2020.

Last reviewed 2020-10-22 · How we verify

NCT03089931: LBP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Change of Lumbar Symptom After Surgical Treatment for Patients With Cervical Stenosis

Completed Last updated 22 October 2020

What this trial tests

trial testing Cervical spinal surgery in Cervical Myelopathy Spondylosis in 100 participants. Completed in 15 October 2020.

Timeline

11 November 2012

Primary endpoint
15 October 2020

15 October 2020

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	11 November 2012
Primary completion	15 October 2020
Estimated completion	15 October 2020
Sites	1 location across South Korea

Drugs / interventions tested

Cervical spinal surgery

Conditions studied

Cervical Myelopathy Spondylosis — all drugs for Cervical Myelopathy Spondylosis →
Low Back Pain — all drugs for Low Back Pain →

Sponsor

Seoul National University Hospital

Who can join

Adults 18 to 90, any sex, with Cervical Myelopathy Spondylosis or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low back pain may be reduced after cervical spinal surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03089931 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 22 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03089931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing